Bridging the Treatment Access Gap: Janus Kinase Inhibitors as First-line Advanced Therapy for Inflammatory Bowel Disease in Resource-variable Settings.
Journal: Euroasian journal of hepato-gastroenterology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Bandaranaike R, Hewitt B, Tarwater S (2026). "Bridging the Treatment Access Gap: Janus Kinase Inhibitors as First-line Advanced Therapy for Inflammatory Bowel Disease in Resource-variable Settings.". Euroasian journal of hepato-gastroenterology. https://doi.org/10.5005/jp-journals-10018-1503